Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors

  1. El Zarif, T.
  2. Nassar, A.H.
  3. Pond, G.R.
  4. Zhuang, T.Z.
  5. Master, V.
  6. Nazha, B.
  7. Niglio, S.
  8. Simon, N.
  9. Hahn, A.W.
  10. Pettaway, C.A.
  11. Tu, S.-M.
  12. Abdel-Wahab, N.
  13. Velev, M.
  14. Flippot, R.
  15. Buti, S.
  16. Maruzzo, M.
  17. Mittra, A.
  18. Gheeya, J.
  19. Yang, Y.
  20. Rodriguez, P.A.
  21. Castellano, D.
  22. de Velasco, G.
  23. Roviello, G.
  24. Antonuzzo, L.
  25. McKay, R.R.
  26. Vincenzi, B.
  27. Cortellini, A.
  28. Hui, G.
  29. Drakaki, A.
  30. Glover, M.
  31. Khaki, A.R.
  32. El-Am, E.
  33. Adra, N.
  34. Mouhieddine, T.H.
  35. Patel, V.
  36. Piedra, A.
  37. Gernone, A.
  38. Davis, N.B.
  39. Matthews, H.
  40. Harrison, M.R.
  41. Kanesvaran, R.
  42. Giudice, G.C.
  43. Barata, P.
  44. Farolfi, A.
  45. Lee, J.L.
  46. Milowsky, M.I.
  47. Stahlfeld, C.
  48. Appleman, L.
  49. Kim, J.W.
  50. Freeman, D.
  51. Choueiri, T.K.
  52. Spiess, P.E.
  53. Necchi, A.
  54. Apolo, A.B.
  55. Sonpavde, G.P.
  56. Show all authors +
Journal:
Journal of the National Cancer Institute

ISSN: 1460-2105

Year of publication: 2023

Volume: 115

Issue: 12

Pages: 1605-1615

Type: Article

DOI: 10.1093/JNCI/DJAD155 GOOGLE SCHOLAR